Lisa Rimsza, MD, Pathology, Scottsdale, AZ, Banner Payson Medical Center

LisaMRimszaMD

Pathology Scottsdale, AZ

Hematopathology, Anatomic Pathology, Clinical Pathology

Professor, Pathology, University of Arizona College of Medicine

Dr. Rimsza is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rimsza's full profile

Already have an account?

Education & Training

  • University of New Mexico
    University of New MexicoFELLOWSHIP
  • University of Arizona
    University of ArizonaRESIDENCY
  • University of Arizona College of Medicine - Tucson
    University of Arizona College of Medicine - TucsonMEDICAL_SCHOOL

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1998 - 2005
  • NM State Medical License
    NM State Medical License 1996 - 1998
  • AZ State Medical License
    AZ State Medical License 1994 - 2021
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Validation of the MCL35 Gene Expression Proliferation Assay in Randomized Trials of the European Mantle Cell Lymphoma Network  
    Lisa Rimsza, MD, British Journal of Haematology
  • The MCL35 Gene Expression Proliferation Assay Predicts High‐Risk MCL Patients in a Norwegian Cohort of Younger Patients Given Intensive First Line Therapy  
    Lisa Rimsza, MD, British Journal of Haematology

Abstracts/Posters

  • Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 Study
    Lisa M. Rimsza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • PET-Directed Therapy for Patients with Limited-Stage Diffuse Large B-Cell Lymphoma - Results of Intergroup Nctn Study S1001
    Lisa M. Rimsza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Intraclonal Heterogeneity Caused By Activation-Induced Cytidine Deaminase Is Not a Prognostic Biomarker in Untreated Advanced Stage Follicular Lymphoma: An Analysis of...
    Lisa M. Rimsza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Five-Year Outcomes of SWOG S0: A Randomized Phase II US Intergroup Study of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplant for Patients with Ma... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Enhanced DNA Repair and Genomic Stability in HIV(+) Diffuse Large B Cell Lymphoma of Germinal Center Origin 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Surinder K. Puri Memorial Lecture - Lisa Rimsza, MD
    Surinder K. Puri Memorial Lecture - Lisa Rimsza, MDFebruary 14, 2020
  • Science Saturday: Quest to Unmask an Elusive Immune Cancer
    Science Saturday: Quest to Unmask an Elusive Immune CancerSeptember 08, 2018
  • Mayo Clinic Develops Precision Medicine Genomic Diagnostic Test for Lymphoma
    Mayo Clinic Develops Precision Medicine Genomic Diagnostic Test for LymphomaDecember 22, 2016

Grant Support

  • Molecular Diagnosis And Prognosis In Aggressive LymphomaNational Cancer Institute2011
  • Cb: Tissue CoreNational Cancer Institute2008–2011

Hospital Affiliations